MedMira
我们是谁？
MedMira is a Canadian biotechnology company dedicated to improving human health
with our patented Rapid Vertical Flow (RVF) Technology™ platform and rapid testing
solutions. RVF Technology enables best-in-class speed, multiplex results, and versatility
in any setting.
RVF Technology is the basis for MedMira’s commercialized product range that helps
healthcare providers and agencies combat COVID-19, HIV, hepatitis, syphilis, and other infectious
and sexually transmitted diseases. We have also established a research product line
that facilitates technology licensing, contract manufacturing, and regulatory consulting
revenue streams by enabling other researchers and collaborators to access MedMira
RVF Technology for the development and commercialization of new rapid tests.
Faced with decreasing budgets and resources, healthcare providers require high quality
rapid tests that deliver efficiency in every way, from performance to results. With the
unique capability of enabling multiplex results on one test device with just one drop of
specimen, we are delivering a new class of rapid testing solutions to our customers.
我们的价值观
Our technology platform is a practical and scalable innovation that has the potential to
improve the wellbeing of people around the world. RVF Technology is the core engine
behind our world-class rapid testing solutions for infectious, sexually transmitted
diseases and other chronic healthcare conditions.
Speed and multiplexing are the hallmarks of our technology, which has endured the
most rigorous medical device approval processes in the world and validated by
healthcare providers, governments, and aid organizations. Our technology has been
proven in highly complex regulatory markets around the world including the United
States (FDA), Canada (Health Canada), Europe (CE) and China (CFDA).